0665 4160 (Lithium Carbonate 300 mg)
Pill with imprint 0665 4160 is White, and has been identified as Lithium Carbonate 300 mg. It is supplied by Watson Pharmaceuticals.
Lithium is used in the treatment of bipolar disorder; schizoaffective disorder; mania and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 0665 4160
Lithium Carbonate
- Imprint
- 0665 4160
- Strength
- 300 mg
- Color
- White
- Availability
- Prescription only
- Drug Class
- Antimanic agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00364-0855 (Discontinued)
More about lithium
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (440)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: antimanic agents
Patient resources
- Drug Information
- Lithium (Advanced Reading)
- Lithium Capsules and Tablets
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Syrup and Oral Solution
- Other brands
- Lithobid, Eskalith, Eskalith-CR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.